The US$ 661.71 Billion Fanconi Anemia Drug Market Is Driven By...

added blog Health

2024-02-26 11:54:42 -

The US$ 661.71 Billion Fanconi Anemia Drug Market Is Driven By Increasing Launches Of New Targeted Therapies.

Key TakeawaysKey players operating in the fanconi anemia drug market are Abbott Laboratories, Pfizer Inc., Abbvie Inc., Biocon, F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Astrazeneca Plc., Illumina, Inc., Sanofi S.A., Qiagen, Twist Bioscience, Thermo Fisher Scientific Inc., Biointron, Merck & Co., Inc., Sino Biological Inc., GeneWiz (Azenta Life Sciences), Danaher Corporation, and Synbio...

0 Comments 0 Shares 1K Views 0 Reviews